Phase 2 PROM Clinical Trials
8 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–8 of 8 trials
Recruiting
Phase 2
Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Acute Promyelocytic Leukemia With PML-RARA
M.D. Anderson Cancer Center151 enrolled5 locationsNCT01409161
Recruiting
Phase 2
Zanubrutinib, Obinutuzumab, and Lenalidomide (ZGR) in the Treatment of Newly Diagnosed Splenic B-cell Lymphoma With Prominent Nucleoli (SBLPN): A Prospective, Open-label, Single-arm Clinical Trial
Splenic B-cell Lymphoma/Leukaemia With Prominent Nucleoli，SBLPN
Institute of Hematology & Blood Diseases Hospital, China47 enrolled1 locationNCT07165769
Recruiting
Phase 2
Frontline Oral Arsenic Trioxide for APL
Acute Promyelocytic Leukemia
The University of Hong Kong100 enrolled2 locationsNCT04687176
Recruiting
Phase 2
Oral Arsenic With ATRA for Newly Diagnosed Patients With Acute Promyelocytic Leukemia
Acute Promyelocytic Leukemia (APL)
Instituto do Cancer do Estado de São Paulo115 enrolled1 locationNCT06982274
Recruiting
Phase 2
Treatment Study for Children and Adolescents With Acute Promyelocytic Leukemia
Acute Promyelocytic Leukemia
Associazione Italiana Ematologia Oncologia Pediatrica89 enrolled31 locationsNCT04793919
Terminated
Phase 2
Oral Triple Combination Antiviral Drug Therapy for Treatment of Influenza A in Immunocompromised Subjects
Immune compromisedInfluenza A
Adamas Pharmaceuticals, Inc125 enrolled1 locationACTRN12609000708257
Completed
Phase 2
A phase II trial in patients with acute promyelocytic leukaemia (APML) to evaluate the effects of: all-trans retinoic acid combined with intensive idarubicin during induction and consolidation; subsequent intermittent all-trans retinoic acid; and molecular monitorting for evidence of minimal residual leukaemia and for evidence of incipient relapse.
Acute promyelocytic leukaemia
Australasian Leukaemia and Lymphoma Group100 enrolled1 locationACTRN12607000410459
Completed
Phase 2
Acute Promyelocytic Leukaemia APML4 Protocol
Acute promyelocytic leukaemia (APL)
Australasian Leukaemia and Lymphoma Group125 enrolled28 locationsACTRN12605000070639